Amgen Total Assets from 2010 to 2026

AMG Stock  EUR 317.75  6.70  2.07%   
Amgen Total Assets yearly trend continues to be very stable with very little volatility. Total Assets are likely to drop to about 82.8 B. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2019-03-31
Previous Quarter
90.1 B
Current Value
90.6 B
Quarterly Volatility
14.7 B
 
Covid
 
Interest Hikes
Check Amgen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amgen's main balance sheet or income statement drivers, such as Tax Provision of 1.4 B, Interest Income of 218.9 M or Interest Expense of 1.7 B, as well as many indicators such as . Amgen financial statements analysis is a perfect complement when working with Amgen Valuation or Volatility modules.
  
This module can also supplement various Amgen Technical models . Check out the analysis of Amgen Correlation against competitors.
Evaluating Amgen's Total Assets across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Amgen Inc's fundamental strength.

Latest Amgen's Total Assets Growth Pattern

Below is the plot of the Total Assets of Amgen Inc over the last few years. Total assets refers to the total amount of Amgen assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Amgen Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Amgen's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amgen's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 90.59 B10 Years Trend
Pretty Stable
   Total Assets   
       Timeline  

Amgen Total Assets Regression Statistics

Arithmetic Mean76,532,280,000
Geometric Mean75,815,149,570
Coefficient Of Variation14.06
Mean Deviation7,918,164,706
Median77,626,000,000
Standard Deviation10,760,070,162
Sample Variance115779109.9T
Range37.4B
R-Value0.19
Mean Square Error119003882.4T
R-Squared0.04
Significance0.46
Slope406,465,882
Total Sum of Squares1852465758.1T

Amgen Total Assets History

202682.8 B
202590.6 B
202491.8 B
202397.2 B
202265.1 B
202161.2 B
202062.9 B

About Amgen Financial Statements

Amgen investors utilize fundamental indicators, such as Total Assets, to predict how Amgen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Assets90.6 B82.8 B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out the analysis of Amgen Correlation against competitors.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Understanding that Amgen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Amgen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Amgen's market price signifies the transaction level at which participants voluntarily complete trades.